Bio-Techne (TECH) financials

Life Sciences Tools & Services · NASDAQ · Health Care

$72.66 -0.07% Close Oct 30, 2026 Live

Bio-Techne revenue and earnings by year

Bio-Techne's revenue was $1.22 billion in the fiscal year to June 30, 2026, down 0.4% from the year before. Net income was $182 million, 15.0% of revenue. Since the fiscal year to June 30, 2017, revenue has grown 8.9% a year on average.

RevenueNet income
$500M$1.00B
2017201820192020202120222023202420252026

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 10 fiscal years

In billions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toJun 2026Jun 2025Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017
Revenue1.221.221.161.141.110.930.740.710.640.56
Revenue growth-0.4%5.2%2.0%2.8%18.7%26.0%3.5%11.0%14.2%—
Gross profit0.800.790.770.770.760.630.480.470.430.37
Gross margin65.8%64.8%66.4%67.7%68.4%68.0%65.4%66.3%67.2%66.5%
Operating income0.250.100.210.300.300.240.160.150.140.12
Operating margin20.7%8.4%17.8%26.3%26.8%25.5%21.3%20.5%21.2%21.4%
Net income0.180.070.170.290.270.140.230.100.130.08
Net margin15.0%6.0%14.5%25.1%24.6%15.1%31.0%13.5%19.6%13.5%
Diluted EPS$1.16$0.46$1.05$1.76$1.66$0.87$1.45$0.62$0.82$0.51
Free cash flow0.260.260.240.220.280.310.150.160.150.13

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open TECH in Markets.

See also: TECH valuation and P/E history · TECH returns

No forecast, no recommendation. This page describes Bio-Techne from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.